This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Sanofi-Aventis. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Matthew Mermey: Innovator in Pharmaceutical Formulations
Introduction
Matthew Mermey is a notable inventor based in Leawood, Kansas, who has made significant contributions to the field of pharmaceuticals. He is recognized for his innovative work in developing formulations that enhance the efficacy of medications. His expertise and dedication to research have led to the creation of a patented pharmaceutical product.
Latest Patents
Matthew Mermey holds a patent for a fexofenadine suspension formulation. This invention is directed to an aqueous pharmaceutical suspension of fexofenadine zwitterionic dihydrate Form I. The formulation aims to improve the delivery and effectiveness of the medication, providing a valuable option for patients requiring treatment.
Career Highlights
Matthew Mermey is currently employed at Sanofi-Aventis, a global leader in the pharmaceutical industry. His role at the company allows him to work on cutting-edge research and development projects that aim to improve patient outcomes through innovative drug formulations. His contributions to the field have been recognized by his peers and the industry.
Collaborations
Matthew has collaborated with esteemed colleagues, including Curtis J Porcello and Kazimierz Chrzan. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, ultimately leading to advancements in pharmaceutical formulations.
Conclusion
Matthew Mermey's work in pharmaceutical formulations exemplifies the impact of innovation in healthcare. His patented invention and collaborations highlight his commitment to improving medication delivery and patient care. His contributions continue to shape the future of pharmaceutical research and development.